Cargando…

Apigenin impedes cell cycle progression at G(2) phase in prostate cancer cells

As a natural flavone, apigenin is abundantly present in vegetables, fruits, oregano, tea, chamomile, wheat sprout and is regarded as a major component of the Mediterranean diet. Apigenin is known to inhibit proliferation in different cancer cell lines by inducing G(2)/M arrest, but it is unclear whe...

Descripción completa

Detalles Bibliográficos
Autores principales: Hnit, Su Su Thae, Yao, Mu, Xie, Chanlu, Bi, Ling, Wong, Matthew, Liu, Tao, De Souza, Paul, Li, Zhong, Dong, Qihan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174405/
https://www.ncbi.nlm.nih.gov/pubmed/35670862
http://dx.doi.org/10.1007/s12672-022-00505-1
_version_ 1784722226183929856
author Hnit, Su Su Thae
Yao, Mu
Xie, Chanlu
Bi, Ling
Wong, Matthew
Liu, Tao
De Souza, Paul
Li, Zhong
Dong, Qihan
author_facet Hnit, Su Su Thae
Yao, Mu
Xie, Chanlu
Bi, Ling
Wong, Matthew
Liu, Tao
De Souza, Paul
Li, Zhong
Dong, Qihan
author_sort Hnit, Su Su Thae
collection PubMed
description As a natural flavone, apigenin is abundantly present in vegetables, fruits, oregano, tea, chamomile, wheat sprout and is regarded as a major component of the Mediterranean diet. Apigenin is known to inhibit proliferation in different cancer cell lines by inducing G(2)/M arrest, but it is unclear whether this action is predominantly imposed on G(2) or M phases. In this study, we demonstrate that apigenin arrests prostate cancer cells at G(2) phase by flow cytometric analysis of prostate cancer cells co-stained for phospho-Histone H3 and DNA. Concurrently, apigenin also reduces the mRNA and protein levels of the key regulators that govern G(2)-M transition. Further analysis using chromatin immunoprecipitation (ChIP) confirmed the diminished transcriptional activities of the genes coding for these regulators. Unravelling the inhibitory effect of apigenin on G(2)-M transition in cancer cells provides the mechanistic understanding of its action and supports the potential for apigenin as an anti-cancer agent. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12672-022-00505-1.
format Online
Article
Text
id pubmed-9174405
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-91744052022-06-09 Apigenin impedes cell cycle progression at G(2) phase in prostate cancer cells Hnit, Su Su Thae Yao, Mu Xie, Chanlu Bi, Ling Wong, Matthew Liu, Tao De Souza, Paul Li, Zhong Dong, Qihan Discov Oncol Research As a natural flavone, apigenin is abundantly present in vegetables, fruits, oregano, tea, chamomile, wheat sprout and is regarded as a major component of the Mediterranean diet. Apigenin is known to inhibit proliferation in different cancer cell lines by inducing G(2)/M arrest, but it is unclear whether this action is predominantly imposed on G(2) or M phases. In this study, we demonstrate that apigenin arrests prostate cancer cells at G(2) phase by flow cytometric analysis of prostate cancer cells co-stained for phospho-Histone H3 and DNA. Concurrently, apigenin also reduces the mRNA and protein levels of the key regulators that govern G(2)-M transition. Further analysis using chromatin immunoprecipitation (ChIP) confirmed the diminished transcriptional activities of the genes coding for these regulators. Unravelling the inhibitory effect of apigenin on G(2)-M transition in cancer cells provides the mechanistic understanding of its action and supports the potential for apigenin as an anti-cancer agent. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12672-022-00505-1. Springer US 2022-06-07 /pmc/articles/PMC9174405/ /pubmed/35670862 http://dx.doi.org/10.1007/s12672-022-00505-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Hnit, Su Su Thae
Yao, Mu
Xie, Chanlu
Bi, Ling
Wong, Matthew
Liu, Tao
De Souza, Paul
Li, Zhong
Dong, Qihan
Apigenin impedes cell cycle progression at G(2) phase in prostate cancer cells
title Apigenin impedes cell cycle progression at G(2) phase in prostate cancer cells
title_full Apigenin impedes cell cycle progression at G(2) phase in prostate cancer cells
title_fullStr Apigenin impedes cell cycle progression at G(2) phase in prostate cancer cells
title_full_unstemmed Apigenin impedes cell cycle progression at G(2) phase in prostate cancer cells
title_short Apigenin impedes cell cycle progression at G(2) phase in prostate cancer cells
title_sort apigenin impedes cell cycle progression at g(2) phase in prostate cancer cells
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174405/
https://www.ncbi.nlm.nih.gov/pubmed/35670862
http://dx.doi.org/10.1007/s12672-022-00505-1
work_keys_str_mv AT hnitsusuthae apigeninimpedescellcycleprogressionatg2phaseinprostatecancercells
AT yaomu apigeninimpedescellcycleprogressionatg2phaseinprostatecancercells
AT xiechanlu apigeninimpedescellcycleprogressionatg2phaseinprostatecancercells
AT biling apigeninimpedescellcycleprogressionatg2phaseinprostatecancercells
AT wongmatthew apigeninimpedescellcycleprogressionatg2phaseinprostatecancercells
AT liutao apigeninimpedescellcycleprogressionatg2phaseinprostatecancercells
AT desouzapaul apigeninimpedescellcycleprogressionatg2phaseinprostatecancercells
AT lizhong apigeninimpedescellcycleprogressionatg2phaseinprostatecancercells
AT dongqihan apigeninimpedescellcycleprogressionatg2phaseinprostatecancercells